US Stock MarketDetailed Quotes

LBPH Longboard Pharmaceuticals

Watchlist

59.770
0.0000.00%

Close Nov 21 16:00 ET

59.770
0.0000.00%

Post 17:52 ET

2.33BMarket Cap-26564P/E (TTM)

Longboard Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-54.98%-20.6M

-42.20%-19.13M

-15.88%-15.18M

-33.64%-50.87M

-14.03%-11.03M

-34.87%-13.29M

-58.02%-13.45M

-30.64%-13.1M

-54.07%-38.06M

-70.41%-9.67M

Net income from continuing operations

-89.73%-24.54M

-45.24%-21.79M

-30.81%-14.99M

-23.84%-54.42M

-32.51%-15.03M

-11.54%-12.93M

-31.49%-15M

-19.37%-11.46M

-58.09%-43.95M

-29.32%-11.35M

Depreciation and amortization

0.00%1K

0.00%2K

0.00%1K

0.00%5K

0.00%1K

0.00%2K

0.00%1K

400.00%5K

0.00%1K

Change In working capital

397.52%3M

169.52%2.89M

96.07%-92K

-59.38%1.27M

184.88%3.54M

-221.13%-1.01M

-50.96%1.07M

-104.19%-2.34M

222.54%3.12M

-50.24%1.24M

-Change in prepaid assets

-423.35%-637K

-479.33%-1.58M

3.51%-770K

304.37%374K

-11.55%559K

-11.26%197K

-68.96%416K

66.43%-798K

88.88%-183K

-41.59%632K

-Change in payables and accrued expense

186.64%1.55M

2,639.68%3.45M

1,428.57%3M

-101.79%-42K

701.27%1.43M

-4,260.47%-1.79M

-53.51%126K

-91.35%196K

81.63%2.34M

-127.82%-237K

-Change in other working capital

258.32%2.09M

91.71%1.02M

-33.53%-2.32M

-2.50%935K

83.61%1.56M

2.64%583K

-7.97%531K

-67.89%-1.74M

-27.46%959K

50.35%848K

Cash from discontinued investing activities

Operating cash flow

-54.98%-20.6M

-42.20%-19.13M

-15.88%-15.18M

-33.64%-50.87M

-14.03%-11.03M

-34.87%-13.29M

-58.02%-13.45M

-30.64%-13.1M

-54.07%-38.06M

-70.41%-9.67M

Investing cash flow

Cash flow from continuing investing activities

181.27%33.05M

-359.81%-20.69M

-3,896.14%-230.92M

242.01%24.23M

-172.77%-1.56M

1,232.09%11.75M

567.39%7.96M

128.58%6.08M

58.09%-17.06M

162.35%2.15M

Net investment purchase and sale

181.27%33.05M

-359.81%-20.69M

-3,896.14%-230.92M

242.01%24.23M

-172.77%-1.56M

1,232.09%11.75M

567.39%7.96M

128.58%6.08M

58.07%-17.06M

162.41%2.15M

Cash from discontinued investing activities

Investing cash flow

181.27%33.05M

-359.81%-20.69M

-3,896.14%-230.92M

242.01%24.23M

-172.77%-1.56M

1,232.09%11.75M

567.39%7.96M

128.58%6.08M

58.09%-17.06M

162.35%2.15M

Financing cash flow

Cash flow from continuing financing activities

-90.58%560K

116.80%21K

1,240.84%286.4M

6,899.77%30.19M

777.93%3.01M

5.95M

-125K

21.36M

-100.58%-444K

-444K

Net common stock issuance

--0

1,210.22%301.35M

--31.79M

--2.83M

--5.96M

--0

--23M

--0

Proceeds from stock option exercised by employees

239.66%591K

-47.92%25K

--48K

--490K

--268K

--174K

--48K

--0

Net other financing activities

83.51%-31K

97.69%-4K

-814.27%-14.99M

-369.82%-2.09M

---85K

---188K

---173K

---1.64M

94.66%-444K

----

Cash from discontinued financing activities

Financing cash flow

-90.58%560K

116.80%21K

1,240.84%286.4M

6,899.77%30.19M

777.93%3.01M

--5.95M

---125K

--21.36M

-100.58%-444K

---444K

Net cash flow

Beginning cash position

-23.90%14.84M

117.50%54.64M

33.00%14.33M

-83.76%10.78M

27.55%23.91M

-29.63%19.5M

-28.30%25.12M

-83.76%10.78M

19.94%66.35M

-75.16%18.75M

Current changes in cash

195.30%13.01M

-608.49%-39.8M

180.97%40.31M

106.40%3.56M

-20.19%-9.58M

149.11%4.41M

23.28%-5.62M

145.82%14.35M

-603.82%-55.57M

12.56%-7.97M

End cash Position

16.50%27.85M

-23.90%14.84M

117.50%54.64M

33.00%14.33M

27.55%23.91M

-29.63%19.5M

-28.30%25.12M

-83.76%10.78M

Free cash flow

-54.98%-20.6M

-42.20%-19.13M

-15.88%-15.18M

-33.64%-50.87M

-14.03%-11.03M

-34.87%-13.29M

-58.02%-13.45M

-30.64%-13.1M

-53.97%-38.06M

-70.32%-9.67M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-54.98%-20.6M	-42.20%-19.13M	-15.88%-15.18M	-33.64%-50.87M	-14.03%-11.03M	-34.87%-13.29M	-58.02%-13.45M	-30.64%-13.1M	-54.07%-38.06M	-70.41%-9.67M
Net income from continuing operations	-89.73%-24.54M	-45.24%-21.79M	-30.81%-14.99M	-23.84%-54.42M	-32.51%-15.03M	-11.54%-12.93M	-31.49%-15M	-19.37%-11.46M	-58.09%-43.95M	-29.32%-11.35M
Depreciation and amortization	0.00%1K	0.00%2K	0.00%1K	0.00%5K	0.00%1K	0.00%1K	0.00%2K	0.00%1K	400.00%5K	0.00%1K
Change In working capital	397.52%3M	169.52%2.89M	96.07%-92K	-59.38%1.27M	184.88%3.54M	-221.13%-1.01M	-50.96%1.07M	-104.19%-2.34M	222.54%3.12M	-50.24%1.24M
-Change in prepaid assets	-423.35%-637K	-479.33%-1.58M	3.51%-770K	304.37%374K	-11.55%559K	-11.26%197K	-68.96%416K	66.43%-798K	88.88%-183K	-41.59%632K
-Change in payables and accrued expense	186.64%1.55M	2,639.68%3.45M	1,428.57%3M	-101.79%-42K	701.27%1.43M	-4,260.47%-1.79M	-53.51%126K	-91.35%196K	81.63%2.34M	-127.82%-237K
-Change in other working capital	258.32%2.09M	91.71%1.02M	-33.53%-2.32M	-2.50%935K	83.61%1.56M	2.64%583K	-7.97%531K	-67.89%-1.74M	-27.46%959K	50.35%848K
Cash from discontinued investing activities
Operating cash flow	-54.98%-20.6M	-42.20%-19.13M	-15.88%-15.18M	-33.64%-50.87M	-14.03%-11.03M	-34.87%-13.29M	-58.02%-13.45M	-30.64%-13.1M	-54.07%-38.06M	-70.41%-9.67M
Investing cash flow
Cash flow from continuing investing activities	181.27%33.05M	-359.81%-20.69M	-3,896.14%-230.92M	242.01%24.23M	-172.77%-1.56M	1,232.09%11.75M	567.39%7.96M	128.58%6.08M	58.09%-17.06M	162.35%2.15M
Net investment purchase and sale	181.27%33.05M	-359.81%-20.69M	-3,896.14%-230.92M	242.01%24.23M	-172.77%-1.56M	1,232.09%11.75M	567.39%7.96M	128.58%6.08M	58.07%-17.06M	162.41%2.15M
Cash from discontinued investing activities
Investing cash flow	181.27%33.05M	-359.81%-20.69M	-3,896.14%-230.92M	242.01%24.23M	-172.77%-1.56M	1,232.09%11.75M	567.39%7.96M	128.58%6.08M	58.09%-17.06M	162.35%2.15M
Financing cash flow
Cash flow from continuing financing activities	-90.58%560K	116.80%21K	1,240.84%286.4M	6,899.77%30.19M	777.93%3.01M	5.95M	-125K	21.36M	-100.58%-444K	-444K
Net common stock issuance	--0	--0	1,210.22%301.35M	--31.79M	--2.83M	--5.96M	--0	--23M	--0	--0
Proceeds from stock option exercised by employees	239.66%591K	-47.92%25K	--48K	--490K	--268K	--174K	--48K	--0	--0	--0
Net other financing activities	83.51%-31K	97.69%-4K	-814.27%-14.99M	-369.82%-2.09M	---85K	---188K	---173K	---1.64M	94.66%-444K	----
Cash from discontinued financing activities
Financing cash flow	-90.58%560K	116.80%21K	1,240.84%286.4M	6,899.77%30.19M	777.93%3.01M	--5.95M	---125K	--21.36M	-100.58%-444K	---444K
Net cash flow
Beginning cash position	-23.90%14.84M	117.50%54.64M	33.00%14.33M	-83.76%10.78M	27.55%23.91M	-29.63%19.5M	-28.30%25.12M	-83.76%10.78M	19.94%66.35M	-75.16%18.75M
Current changes in cash	195.30%13.01M	-608.49%-39.8M	180.97%40.31M	106.40%3.56M	-20.19%-9.58M	149.11%4.41M	23.28%-5.62M	145.82%14.35M	-603.82%-55.57M	12.56%-7.97M
End cash Position	16.50%27.85M	-23.90%14.84M	117.50%54.64M	33.00%14.33M	33.00%14.33M	27.55%23.91M	-29.63%19.5M	-28.30%25.12M	-83.76%10.78M	-83.76%10.78M
Free cash flow	-54.98%-20.6M	-42.20%-19.13M	-15.88%-15.18M	-33.64%-50.87M	-14.03%-11.03M	-34.87%-13.29M	-58.02%-13.45M	-30.64%-13.1M	-53.97%-38.06M	-70.32%-9.67M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data